Mitchell Mcleod Pugh & Williams Inc Novartis Ag Transaction History

Mitchell Mcleod Pugh & Williams Inc

$476 Million
Q3 2024

A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Novartis Ag stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 5,979 shares of NVS stock, worth $588,034. This represents 0.14% of its overall portfolio holdings.

Number of Shares

5,979

Previous 5,954 0.42%

Holding current value

$588,034

Previous $633,000 8.53%

% of portfolio

0.14%

Previous 0.15%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$106.13 - $120.89 $2,653 - $3,022	25 Added 0.42%	5,979 $687,000
Q3 2023 Oct 20, 2023	BUY	$94.73 - $105.13 $28,419 - $31,539	300 Added 5.31%	5,954 $606,000
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $2,000 - $2,320	-25 Reduced 0.44%	5,654 $520,000
Q4 2022 Feb 03, 2023	SELL	$75.55 - $92.52 $20,096 - $24,610	-266 Reduced 4.47%	5,679 $515,000
Q3 2022 Nov 07, 2022	BUY	$74.61 - $87.26 $40,364 - $47,207	541 Added 10.01%	5,945 $452,000
Q2 2022 Nov 18, 2022	SELL	$80.52 - $93.75 $43,561 - $50,718	-541 Reduced 9.1%	5,404 $457,000
Q1 2022 Apr 26, 2022	BUY	$80.11 - $90.62 $20,828 - $23,561	260 Added 5.05%	5,404 $474,000
Q2 2020 Jul 17, 2020	BUY	$80.93 - $91.1 $90,641 - $102,032	1,120 Added 27.83%	5,144 $449,000
Q1 2020 Apr 08, 2020	BUY	$70.67 - $99.01 $22,614 - $31,683	320 Added 8.64%	4,024 $332,000
Q2 2019 Jul 09, 2019	SELL	$75.4 - $92.8 $18,925 - $23,292	-251 Reduced 6.35%	3,704 $338,000
Q1 2019 Apr 11, 2019	BUY	$75.32 - $86.15 $85,186 - $97,435	1,131 Added 40.05%	3,955 $380,000
Q4 2018 Jan 10, 2019	BUY	$73.66 - $82.02 $8,102 - $9,022	110 Added 4.05%	2,824 $242,000
Q3 2017 Oct 12, 2017	BUY	$74.14 - $77.27 $201,215 - $209,710	2,714	2,714 $233,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.

Account

Mitchell Mcleod Pugh & Williams Inc Novartis Ag Transaction History